Dimenhydrinate PCD Pharma Franchise Company
Cafoli Lifecare offers a Dimenhydrinate range of 2 tablet formulations, manufactured in WHO-GMP certified facilities. Distributors serving ENT, general practice and paediatric prescribers can secure district-wise monopoly franchise rights for this anti-vertigo and anti-emetic molecule with full promotional support.
What is Dimenhydrinate?
Dimenhydrinate is an antihistamine with anti-emetic and anti-vertigo action. By dampening over-stimulation of the vestibular system and the vomiting centre, it prevents and relieves nausea, vomiting and dizziness, particularly from motion sickness and vertigo. Reference: PubChem - Dimenhydrinate.
Available Forms
The Cafoli Dimenhydrinate portfolio is offered as oral Tablets in the commonly prescribed strengths. Contact us for current pack presentations and combinations.
Therapeutic Applications
Dimenhydrinate is used to prevent and treat motion sickness, and to relieve nausea, vomiting and dizziness associated with vertigo and vestibular disorders. Prescribers include ENT specialists, physicians, paediatricians and general practitioners.
Why Dimenhydrinate is a High-Potential Molecule for Distributors
Motion sickness and vertigo-related nausea are common everyday complaints, and dimenhydrinate is a trusted, low-cost, OTC-familiar remedy with broad chemist demand across all age groups. Its dependable, high-frequency use makes it an easy add-on to an ENT and general-practice portfolio.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.
References
- PubChem: Dimenhydrinate
- MedlinePlus: Dimenhydrinate
- PubMed: dimenhydrinate in motion sickness and vertigo
Our formulations of Dimenhydrinate find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: